Triple negative breast cancer

That this House recognises the significant impact of triple negative breast cancer (TNBC), which accounts for around 15% of breast cancer diagnosis but up to 40% of all breast cancer deaths in England; acknowledges that TNBC disproportionately affects people under the age of 40, for whom a diagnosis and treatment can have a profound effect on their lives, employment, financial security and family; further recognises the impact of undergoing treatment for TNBC and the importance of the breast cancer workforce in providing support during this time, particularly Clinical Nurse Specialists (CNS); acknowledges the lack of specific data on TNBC in England, making it difficult to identify exactly how many people are living with or dying from TNBC; and calls on the Government to ensure that every person with TNBC has care tailored to their needs, including the assignment of a CNS at diagnosis and that TNBC data is improved in England.